{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T16:05:43Z","timestamp":1783181143278,"version":"3.54.6"},"reference-count":72,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T00:00:00Z","timestamp":1735257600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.bbalip.2024.159590","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T17:03:21Z","timestamp":1734627801000},"page":"159590","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Hippo pathway activation causes multiple lipid derangements in a murine model of cardiomyopathy"],"prefix":"10.1016","volume":"1870","author":[{"given":"Wei","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Chan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"She","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thy","family":"Duong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Ziemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Bo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-Ling","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Meikle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Jun","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbalip.2024.159590_bb0005","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0140-6736(23)01241-2","article-title":"Dilated cardiomyopathy: causes, mechanisms, and current and future treatment approaches","volume":"402","author":"Heymans","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.bbalip.2024.159590_bb0010","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1172\/JCI120849","article-title":"Mitochondrial dysfunction in pathophysiology of heart failure","volume":"128","author":"Zhou","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2024.159590_bb0015","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1161\/CIRCULATIONAHA.111.060889","article-title":"Ventricular assist device implantation corrects myocardial lipotoxicity, reverses insulin resistance, and normalizes cardiac metabolism in patients with advanced heart failure","volume":"125","author":"Chokshi","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.bbalip.2024.159590_bb0020","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1136\/heartjnl-2013-304961","article-title":"Cardiac steatosis in patients with dilated cardiomyopathy","volume":"100","author":"Graner","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.bbalip.2024.159590_bb0025","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1161\/CIRCULATIONAHA.114.011687","article-title":"Dietary fat supply to failing hearts determines dynamic lipid signaling for nuclear receptor activation and oxidation of stored triglyceride","volume":"130","author":"Lahey","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.bbalip.2024.159590_bb0030","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.yjmcc.2007.11.006","article-title":"The absence of endogenous lipid oxidation in early stage heart failure exposes limits in lipid storage and turnover","volume":"44","author":"O\u2019Donnell","year":"2008","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbalip.2024.159590_bb0035","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41569-021-00536-1","article-title":"Ceramides and other sphingolipids as drivers of cardiovascular disease","volume":"18","author":"Choi","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.bbalip.2024.159590_bb0040","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.hfc.2012.06.003","article-title":"Sphingolipids, lipotoxic cardiomyopathy, and cardiac failure","volume":"8","author":"Park","year":"2012","journal-title":"Heart Fail. Clin."},{"key":"10.1016\/j.bbalip.2024.159590_bb0045","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1161\/CIRCULATIONAHA.119.039610","article-title":"Preservation of acyl coenzyme A attenuates pathological and metabolic cardiac remodeling through selective lipid trafficking","volume":"139","author":"Goldenberg","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.bbalip.2024.159590_bb0050","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.yjmcc.2012.06.018","article-title":"Myocardial triacylglycerol metabolism","volume":"55","author":"Kienesberger","year":"2013","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbalip.2024.159590_bb0055","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.118.005708","article-title":"Plasma ceramides and sphingomyelins in relation to heart failure risk","volume":"12","author":"Lemaitre","year":"2019","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.bbalip.2024.159590_bb0060","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1194\/jlr.M400078-JLR200","article-title":"Requirement of PPARalpha in maintaining phospholipid and triacylglycerol homeostasis during energy deprivation","volume":"45","author":"Lee","year":"2004","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2024.159590_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0030101","article-title":"PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis","volume":"3","author":"Leone","year":"2005","journal-title":"PLoS Biol."},{"key":"10.1016\/j.bbalip.2024.159590_bb0070","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/s41569-021-00569-6","article-title":"PPAR control of metabolism and cardiovascular functions","volume":"18","author":"Montaigne","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.bbalip.2024.159590_bb0075","doi-asserted-by":"crossref","first-page":"H584","DOI":"10.1152\/ajpheart.00103.2017","article-title":"Metabolic reprogramming via PPARalpha signaling in cardiac hypertrophy and failure: from metabolomics to epigenetics","volume":"313","author":"Warren","year":"2017","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbalip.2024.159590_bb0080","doi-asserted-by":"crossref","first-page":"4406","DOI":"10.3390\/ijms21124406","article-title":"Downregulation of PPARalpha during experimental left ventricular hypertrophy is critically dependent on Nox2 NADPH oxidase signalling","volume":"21","author":"Harvey","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbalip.2024.159590_bb0085","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ejheart.2005.09.003","article-title":"Cardiac PPARalpha expression in patients with dilated cardiomyopathy","volume":"8","author":"Schupp","year":"2006","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.bbalip.2024.159590_bb0090","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1038\/s41418-020-00732-5","article-title":"TEAD1 protects against necroptosis in postmitotic cardiomyocytes through regulation of nuclear DNA-encoded mitochondrial genes","volume":"28","author":"Liu","year":"2021","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbalip.2024.159590_bb0095","doi-asserted-by":"crossref","first-page":"8993","DOI":"10.7150\/thno.62302","article-title":"Activation of Hippo signaling pathway mediates mitochondria dysfunction and dilated cardiomyopathy in mice","volume":"11","author":"Wu","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.bbalip.2024.159590_bb0100","doi-asserted-by":"crossref","first-page":"13839","DOI":"10.1073\/pnas.1313192110","article-title":"Hippo pathway effector Yap promotes cardiac regeneration","volume":"110","author":"Xin","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbalip.2024.159590_bb0105","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/nature24045","article-title":"Hippo pathway deficiency reverses systolic heart failure after infarction","volume":"550","author":"Leach","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.bbalip.2024.159590_bb0110","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/s41569-018-0063-3","article-title":"The Hippo pathway in the heart: pivotal roles in development, disease, and regeneration","volume":"15","author":"Wang","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.bbalip.2024.159590_bb0115","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1161\/CIRCRESAHA.114.302810","article-title":"The hippo pathway is activated and is a causal mechanism for adipogenesis in arrhythmogenic cardiomyopathy","volume":"114","author":"Chen","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbalip.2024.159590_bb0120","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1172\/JCI17459","article-title":"Activation of Mst1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy","volume":"111","author":"Yamamoto","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2024.159590_bb0125","doi-asserted-by":"crossref","first-page":"96203","DOI":"10.1155\/2010\/612089","article-title":"Peroxisome proliferator-activated receptor alpha target genes","volume":"2010","author":"Rakhshandehroo","year":"2010","journal-title":"PPAR Res."},{"key":"10.1016\/j.bbalip.2024.159590_bb0130","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1128\/MCB.20.5.1868-1876.2000","article-title":"The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes","volume":"20","author":"Vega","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbalip.2024.159590_bb0135","first-page":"1492","article-title":"Triacylglycerol turnover in the failing heart","volume":"2016","author":"Carley","year":"1861","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2024.159590_bb0140","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1161\/hh2301.100350","article-title":"Sphingolipid mediators in cardiovascular cell biology and pathology","volume":"89","author":"Levade","year":"2001","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbalip.2024.159590_bb0145","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.cmet.2014.01.002","article-title":"Peroxisomes: a nexus for lipid metabolism and cellular signaling","volume":"19","author":"Lodhi","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbalip.2024.159590_bb0150","first-page":"1387","article-title":"Peroxisomal ABC transporters: structure, function and role in disease","volume":"2012","author":"Morita","year":"1822","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2024.159590_bb0155","article-title":"Peroxisomal metabolite and cofactor transport in humans, front cell","volume":"8","author":"Chornyi","year":"2020","journal-title":"Dev. Biol."},{"key":"10.1016\/j.bbalip.2024.159590_bb0160","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s00018-012-1136-9","article-title":"The exportomer: the peroxisomal receptor export machinery","volume":"70","author":"Platta","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbalip.2024.159590_bb0165","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.3390\/cells11132067","article-title":"Insights into the structure and function of the Pex1\/Pex6 AAA-ATPase in peroxisome homeostasis","volume":"11","author":"Judy","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.bbalip.2024.159590_bb0170","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1161\/ATVBAHA.116.307497","article-title":"Circulating ceramides predict cardiovascular outcomes in the population-based FINRISK 2002 cohort","volume":"36","author":"Havulinna","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2024.159590_bb0175","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1161\/CIRCRESAHA.120.317883","article-title":"Lipid profiles and heart failure risk: results from two prospective studies","volume":"128","author":"Wittenbecher","year":"2021","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbalip.2024.159590_bb0180","doi-asserted-by":"crossref","first-page":"H45","DOI":"10.1152\/ajpheart.00609.2018","article-title":"Galectin-3 deficiency ameliorates fibrosis and remodeling in dilated cardiomyopathy mice with enhanced Mst1 signaling","volume":"316","author":"Nguyen","year":"2019","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbalip.2024.159590_bb0185","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1016\/j.celrep.2018.08.017","article-title":"Lipidomic profiles of the heart and circulation in response to exercise versus cardiac pathology: a resource of potential biomarkers and drug targets","volume":"24","author":"Tham","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbalip.2024.159590_bb0190","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1194\/jlr.P035808","article-title":"Plasma lipid profiling in a large population-based cohort","volume":"54","author":"Weir","year":"2013","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2024.159590_bb0195","first-page":"71","article-title":"High-throughput plasma lipidomics: detailed mapping of the associations with cardiometabolic risk factors, cell","volume":"26","author":"Huynh","year":"2019","journal-title":"Chem. Biol."},{"key":"10.1016\/j.bbalip.2024.159590_bb0200","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1186\/s12864-020-06856-9","article-title":"mitch: multi-contrast pathway enrichment for multi-omics and single-cell profiling data","volume":"21","author":"Kaspi","year":"2020","journal-title":"BMC Genomics"},{"key":"10.1016\/j.bbalip.2024.159590_bb0205","doi-asserted-by":"crossref","first-page":"D687","DOI":"10.1093\/nar\/gkab1028","article-title":"The reactome pathway knowledgebase 2022","volume":"50","author":"Gillespie","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbalip.2024.159590_bb0210","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1161\/CIRCULATIONAHA.115.017545","article-title":"Evidence for intramyocardial disruption of lipid metabolism and increased myocardial ketone utilization in advanced human heart failure","volume":"133","author":"Bedi","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.bbalip.2024.159590_bb0215","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3390\/jcm9010169","article-title":"Left ventricular function and myocardial triglyceride content on 3T cardiac MR predict major cardiovascular adverse events and readmission in patients hospitalized with acute heart failure","volume":"9","author":"Chang","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bbalip.2024.159590_bb0220","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.96203","article-title":"Increased de novo ceramide synthesis and accumulation in failing myocardium","volume":"2","author":"Ji","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.bbalip.2024.159590_bb0225","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1161\/CIRCULATIONAHA.119.041882","article-title":"Altering sphingolipid metabolism attenuates cell death and inflammatory response after myocardial infarction","volume":"141","author":"Hadas","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.bbalip.2024.159590_bb0230","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1021\/acs.biochem.8b00042","article-title":"Substantial decrease in plasmalogen in the heart associated with Tafazzin deficiency","volume":"57","author":"Kimura","year":"2018","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbalip.2024.159590_bb0235","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/nm.2439","article-title":"ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-alpha and PGC-1","volume":"17","author":"Haemmerle","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbalip.2024.159590_bb0240","doi-asserted-by":"crossref","first-page":"26141","DOI":"10.1074\/jbc.M115.671842","article-title":"G0\/G1 switch gene 2 regulates cardiac lipolysis","volume":"290","author":"Heier","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2024.159590_bb0245","doi-asserted-by":"crossref","DOI":"10.1155\/2008\/253817","article-title":"The PPARalpha-PGC-1alpha axis controls cardiac energy metabolism in healthy and diseased myocardium","volume":"2008","author":"Duncan","year":"2008","journal-title":"PPAR Res."},{"key":"10.1016\/j.bbalip.2024.159590_bb0250","doi-asserted-by":"crossref","first-page":"560","DOI":"10.7150\/thno.79227","article-title":"Hippo pathway activation mediates chemotherapy-induced anti-cancer effect and cardiomyopathy through causing mitochondrial damage and dysfunction","volume":"13","author":"She","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.bbalip.2024.159590_bb0255","doi-asserted-by":"crossref","first-page":"H89","DOI":"10.1152\/ajpheart.00732.2019","article-title":"Tead1 is essential for mitochondrial function in cardiomyocytes","volume":"319","author":"Liu","year":"2020","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbalip.2024.159590_bb0260","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.bbrc.2007.10.062","article-title":"Hypoxia-inducible factor 1 mediates hypoxia-induced cardiomyocyte lipid accumulation by reducing the DNA binding activity of peroxisome proliferator-activated receptor alpha\/retinoid X receptor","volume":"364","author":"Belanger","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbalip.2024.159590_bb0265","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.freeradbiomed.2021.02.016","article-title":"The role of ceramide accumu- lation in human induced pluripotent stem cell-derived cardiomyocytes on mitochondrial oxidative stress and mitophagy","volume":"167","author":"Bekhite","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbalip.2024.159590_bb0270","doi-asserted-by":"crossref","first-page":"26089","DOI":"10.1074\/jbc.M203997200","article-title":"Fatty acid homeostasis and induction of lipid regulatory genes in skeletal muscles of peroxisome proliferator-activated receptor (PPAR) alpha knock-out mice. Evidence for compensatory regulation by PPAR delta","volume":"277","author":"Muoio","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2024.159590_bb0275","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/cvr\/cvy155","article-title":"Heart specific PGC-1alpha deletion identifies metabolome of cardiac restricted metabolic heart failure","volume":"115","author":"Karkkainen","year":"2019","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbalip.2024.159590_bb0280","doi-asserted-by":"crossref","first-page":"29881","DOI":"10.1074\/jbc.M114.601864","article-title":"Cardiomyocyte-specific loss of diacylglycerol acyltransferase 1 (DGAT1) reproduces the abnormalities in lipids found in severe heart failure","volume":"289","author":"Liu","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2024.159590_bb0285","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1210\/en.2007-1713","article-title":"Lipid droplets in lipogenesis and lipolysis","volume":"149","author":"Ducharme","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbalip.2024.159590_bb0290","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1161\/CIRCRESAHA.116.306842","article-title":"Lipid use and misuse by the heart","volume":"118","author":"Schulze","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbalip.2024.159590_bb0295","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1194\/jlr.M080374","article-title":"Acid sphingomyelinase promotes mitochondrial dysfunction due to glutamate-induced regulated necrosis","volume":"59","author":"Novgorodov","year":"2018","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2024.159590_bb0300","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41419-020-03297-w","article-title":"Acid sphingomyelinase-dependent autophagic degradation of GPX4 is critical for the execution of ferroptosis","volume":"12","author":"Thayyullathil","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbalip.2024.159590_bb0305","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.plipres.2013.07.002","article-title":"Lipids of mitochondria","volume":"52","author":"Horvath","year":"2013","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.bbalip.2024.159590_bb0310","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1016\/j.celrep.2018.02.034","article-title":"Ceramide-protein inter- actions modulate ceramide-associated lipotoxic cardiomyopathy","volume":"22","author":"Walls","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbalip.2024.159590_bb0315","article-title":"Lipid synthesis and transport are coupled to regulate membrane lipid dynamics in the endoplasmic reticulum","volume":"1865","author":"Balla","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.bbalip.2024.159590_bb0320","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/nrm3440","article-title":"Endoplasmic reticulum-mitochondria contacts: function of the junction","volume":"13","author":"Rowland","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbalip.2024.159590_bb0325","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3390\/ijms20051149","article-title":"An updated review of Lysophosphatidylcholine metabolism in human diseases","volume":"20","author":"Law","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbalip.2024.159590_bb0330","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/jnc.14082","article-title":"Reduced muscle strength in ether lipid-deficient mice is accompanied by altered development and function of the neuromuscular junction","volume":"143","author":"Dorninger","year":"2017","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbalip.2024.159590_bb0335","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.bbamcr.2006.08.038","article-title":"The ether lipid-deficient mouse: tracking down plasmalogen functions","volume":"1763","author":"Gorgas","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbalip.2024.159590_bb0340","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s13238-017-0423-5","article-title":"Structural and functional roles of ether lipids","volume":"9","author":"Dean","year":"2018","journal-title":"Protein Cell"},{"key":"10.1016\/j.bbalip.2024.159590_bb0345","doi-asserted-by":"crossref","first-page":"1389456","DOI":"10.3389\/fmmed.2024.1389456","article-title":"Tafazzin deficiency causes substantial remodeling in the lipidome of a mouse model of Barth Syndrome cardiomyopathy","volume":"4","author":"Hachmann","year":"2024","journal-title":"Front. Mol. Med."},{"key":"10.1016\/j.bbalip.2024.159590_bb0350","doi-asserted-by":"crossref","first-page":"8537","DOI":"10.1074\/jbc.M109.083311","article-title":"Posttranslational regulation of fatty acyl-CoA reductase 1, Far1, controls ether glycerophospholipid synthesis","volume":"285","author":"Honsho","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2024.159590_bb0355","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.3390\/ijms24031884","article-title":"Overlapping and distinct features of cardiac pathology in inherited human and murine ether lipid deficiency","volume":"24","author":"Dorninger","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbalip.2024.159590_bb0360","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1002\/jimd.12264","article-title":"Oral batyl alcohol supplementation rescues decreased cardiac conduction in ether phospholipid-deficient mice","volume":"43","author":"Todt","year":"2020","journal-title":"J. Inherit. Metab. Dis."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198124001409?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198124001409?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T01:04:01Z","timestamp":1738458241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1388198124001409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":72,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1388198124001409"],"URL":"https:\/\/doi.org\/10.1016\/j.bbalip.2024.159590","relation":{},"ISSN":["1388-1981"],"issn-type":[{"value":"1388-1981","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hippo pathway activation causes multiple lipid derangements in a murine model of cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbalip.2024.159590","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"159590"}}